Exact Mass: 465.18997620000005
Exact Mass Matches: 465.18997620000005
Found 230 metabolites which its exact mass value is equals to given mass value 465.18997620000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cisapride
C23H29ClFN3O4 (465.18305160000006)
In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
cisapride
C23H29ClFN3O4 (465.18305160000006)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
Biotripyrrin-a
C25H27N3O6 (465.18997620000005)
Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247
Biotripyrrin-b
C25H27N3O6 (465.18997620000005)
Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
C23H31NO7S (465.18211360000004)
Acalabrutinib
Benzylpenicilloyl G
C22H31N3O6S (465.19334660000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-{5-[(2,3,4,5,6-Pentamethylbenzyl)sulfanyl]-4-phenyl-4H-1,2,4-triazol-3-yl}-3-(2-pyridinyl)acrylonitrile
C28H27N5S (465.19870620000006)
CP 34089; Nalador; SHB 286;ZK 57671
C23H31NO7S (465.18211360000004)
Ala Asp Phe Asn
Ala Asp Asn Phe
Ala Phe Asp Asn
Ala Phe Asn Asp
Ala Asn Asp Phe
Ala Asn Phe Asp
Cys Asp Lys Thr
Cys Asp Thr Lys
Cys Glu Lys Ser
Cys Glu Ser Lys
Cys Gly Met Arg
Cys Gly Arg Met
Cys Lys Asp Thr
Cys Lys Glu Ser
Cys Lys Ser Glu
Cys Lys Thr Asp
Cys Met Gly Arg
Cys Met Arg Gly
Cys Arg Gly Met
Cys Arg Met Gly
Cys Ser Glu Lys
Cys Ser Lys Glu
Cys Thr Asp Lys
Cys Thr Lys Asp
Asp Ala Phe Asn
Asp Ala Asn Phe
Asp Cys Lys Thr
Asp Cys Thr Lys
Asp Phe Ala Asn
Asp Phe Gly Gln
Asp Phe Asn Ala
Asp Phe Gln Gly
Asp Gly Phe Gln
Asp Gly Gln Phe
Asp Lys Cys Thr
Asp Lys Thr Cys
Asp Asn Ala Phe
Asp Asn Phe Ala
Asp Gln Phe Gly
Asp Gln Gly Phe
Asp Thr Cys Lys
Asp Thr Lys Cys
Glu Cys Lys Ser
Glu Cys Ser Lys
Glu Phe Gly Asn
Glu Phe Asn Gly
Glu Gly Phe Asn
Glu Gly Asn Phe
Glu Lys Cys Ser
Glu Lys Ser Cys
Glu Asn Phe Gly
Glu Asn Gly Phe
Glu Ser Cys Lys
Glu Ser Lys Cys
Phe Ala Asp Asn
Phe Ala Asn Asp
Phe Asp Ala Asn
Phe Asp Gly Gln
Phe Asp Asn Ala
Phe Asp Gln Gly
Phe Glu Gly Asn
Phe Glu Asn Gly
Phe Gly Asp Gln
Phe Gly Glu Asn
Phe Gly Asn Glu
Phe Gly Gln Asp
Phe Asn Ala Asp
Phe Asn Asp Ala
Phe Asn Glu Gly
Phe Asn Gly Glu
Phe Gln Asp Gly
Phe Gln Gly Asp
Gly Cys Met Arg
Gly Cys Arg Met
Gly Asp Phe Gln
Gly Asp Gln Phe
Gly Glu Phe Asn
Gly Glu Asn Phe
Gly Phe Asp Gln
Gly Phe Glu Asn
Gly Phe Asn Glu
Gly Phe Gln Asp
Gly Met Cys Arg
Gly Met Arg Cys
Gly Asn Glu Phe
Gly Asn Phe Glu
Gly Gln Asp Phe
Gly Gln Phe Asp
Gly Arg Cys Met
Gly Arg Met Cys
Lys Cys Asp Thr
Lys Cys Glu Ser
Lys Cys Ser Glu
Lys Cys Thr Asp
Lys Asp Cys Thr
Lys Asp Thr Cys
Lys Glu Cys Ser
Lys Glu Ser Cys
Lys Ser Cys Glu
Lys Ser Glu Cys
Lys Thr Cys Asp
Lys Thr Asp Cys
Met Cys Gly Arg
Met Cys Arg Gly
Met Gly Cys Arg
Met Gly Arg Cys
Met Asn Thr Thr
Met Gln Ser Thr
Met Gln Thr Ser
Met Arg Cys Gly
Met Arg Gly Cys
Met Ser Gln Thr
Met Ser Thr Gln
Met Thr Asn Thr
Met Thr Gln Ser
Met Thr Ser Gln
Met Thr Thr Asn
Asn Ala Asp Phe
Asn Ala Phe Asp
Asn Asp Ala Phe
Asn Asp Phe Ala
Asn Glu Phe Gly
Asn Glu Gly Phe
Asn Phe Ala Asp
Asn Phe Asp Ala
Asn Phe Glu Gly
Asn Phe Gly Glu
Asn Gly Glu Phe
Asn Gly Phe Glu
Asn Met Thr Thr
Asn Thr Met Thr
Asn Thr Thr Met
Gln Asp Phe Gly
Gln Asp Gly Phe
Gln Phe Asp Gly
Gln Phe Gly Asp
Gln Gly Asp Phe
Gln Gly Phe Asp
Gln Met Ser Thr
Gln Met Thr Ser
Gln Ser Met Thr
Gln Ser Thr Met
Gln Thr Met Ser
Gln Thr Ser Met
Arg Cys Gly Met
Arg Cys Met Gly
Arg Gly Cys Met
Arg Gly Met Cys
Arg Met Cys Gly
Arg Met Gly Cys
Ser Cys Glu Lys
Ser Cys Lys Glu
Ser Glu Cys Lys
Ser Glu Lys Cys
Ser Lys Cys Glu
Ser Lys Glu Cys
Ser Met Gln Thr
Ser Met Thr Gln
Ser Gln Met Thr
Ser Gln Thr Met
Ser Ser Ser Trp
Ser Ser Trp Ser
Ser Thr Met Gln
Ser Thr Gln Met
Ser Trp Ser Ser
Thr Cys Asp Lys
Thr Cys Lys Asp
Thr Asp Cys Lys
Thr Asp Lys Cys
Thr Lys Cys Asp
Thr Lys Asp Cys
Thr Met Asn Thr
Thr Met Gln Ser
Thr Met Ser Gln
Thr Met Thr Asn
Thr Asn Met Thr
Thr Asn Thr Met
Thr Gln Met Ser
Thr Gln Ser Met
Thr Ser Met Gln
Thr Ser Gln Met
Thr Thr Met Asn
Thr Thr Asn Met
Trp Ser Ser Ser
Sulprostone
C23H31NO7S (465.18211360000004)
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D008600 - Menstruation-Inducing Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C78568 - Prostaglandin Analogue
Sarpogrelate Hydrochloride
C24H32ClNO6 (465.19180420000004)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Sarpogrelate hydrochloride (MCI-9042) is a selective 5-HT2R antagonist, with pKis of 8.52, 6.57, and 7.43 for 5-HT2A, 5-HT2B, and 5-HT2C receptors, respectively. Sarpogrelate hydrochloride displays selectivity over 5-HT1, 5-HT3, 5-HT4, α1-, α2- and β-adrenoreceptor, histamine H1, H2 and muscarinic M3 receptors. Sarpogrelate hydrochloride can be used for the research of vascular disease associated with thrombosis[1][2][3].
N-(3,5-DICHLORO-2-HYDROXY-4-METHYLPHENYL)-2-(2,4-DI-TERT-PENTYLPHENOXY)-ACETAMIDE
TERT-BUTYL 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE
C22H31N3O6S (465.19334660000004)
PF-543
C27H31NO4S (465.19736860000006)
D004791 - Enzyme Inhibitors
11-(PYRENE-1-SULFONYLAMINO)UNDECANOIC ACID
C27H31NO4S (465.19736860000006)
Acalabrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(1S,2R)-(-)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE
C27H31NO4S (465.19736860000006)
Bevonium metilsulfate
C23H31NO7S (465.18211360000004)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Tert-Butyl 4-({[4-(But-2-Yn-1-Ylamino)phenyl]sulfonyl}methyl)-4-[(Hydroxyamino)carbonyl]piperidine-1-Carboxylate
C22H31N3O6S (465.19334660000004)
[[(E)-5-[(1S,2S,8aR)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-oxidophosphoryl] phosphate
(Z,Z)-2-[[3-(2-carboxyethyl)-5-[(4-ethenyl-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylene]-2,5-dihydro-4-methyl-5-oxo-1H-Pyrrole-3-propanoate
C25H27N3O6 (465.18997620000005)
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide
C24H27N5O3S (465.18345120000004)
(2E)-5-[(1S,2S,4aR,8aR)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
(2E)-5-[(1R,2R,4aS,8aS)-1-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
[(1S)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
C26H28ClN3O3 (465.1819088000001)
[(1R)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
C26H28ClN3O3 (465.1819088000001)
N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide
Propulsid
C23H29ClFN3O4 (465.18305160000006)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)
(1r,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)
(4r)-4-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentanoic acid
(1s,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)